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Abstract
This study aimed to translate the Partner in Health (PIH) scale (12 items) into the mandarin Chinese
language and investigate the psychometric properties of the Chinese version PIH scale in patients with
chronic diseases in primary care settings in Changsha, China.
The instrument was translated according to the Sousa guideline including the following steps: Forward
translation, back translation, expert panel evaluation and pilot study, with achievement of consensus at
each step. Psychometric properties of the Chinese version PIH were assessed in a random sample of 300
community-dwelling patients with chronic diseases in Changsha, China. These properties included
content validity, internal consistency, test-retest reliability and structural validity.
Survey response rate was 93.7%. The results showed that the Chinese PIH scale had satisfactory
reliability and validity. The test-retest reliability was 0.832 and the Cronbach’s coefficient was 0.865.
The content validity rate (S-CVI/Ave) was 0.965. The correlation between the Patient Activation
Measure (PAM) and the PIH was 0.505 (p<0.001). Results of the confirmatory factor analysis suggest
that the PIH scale consisted of four factors: knowledge, partnership, management and coping.
The Chinese PIH scale yields high reliability and validity. It can be used as a generic self-rated tool to
assess self-management of patients with chronic diseases in China.
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Introduction
Along with the aged population and increasing lifestyle risk
factors, the prevalence of chronic diseases is gradually rising in
China. It has been reported that the incidence of hypertension
and diabetes mellitus were 25.2% and 9.7% in Chinese adults
in 2012 and were on the rise compared with the statistics
figures in 2002. The incidence of malignant tumors in 2012
was 235 per 100,000 which were also on the increase during
the same period [1]. Chronic diseases have become the biggest
health threat and the major burden of diseases in China. The
mortality caused by chronic diseases was 533 per 100,000,
accounting for 86.6% of overall mortality rate in 2012.
The Chronic Care model offers a framework for the health care
system to effectively deal with the needs and concerns of
individuals with chronic diseases and it is widely
acknowledged that self-management by the patient is integral
to good chronic disease care [2,3]. Besides, accumulated
evidence has shown that effective self-management support
and interventions by service providers improve health
outcomes of patients with chronic disease, enhance patient’s
quality of life, and reduce health service utilization [4]. China’s
government, also recognizing the importance of self-
management, enacted the relevant policy to integrate self-
management into chronic disease management routine practice
in 2010.
There is no agreed definition of self-management in the world
though it is generally understood to include a focus on the
person’s knowledge and behaviours, and how they manage the
physical, social and emotional impacts of chronic disease on
their everyday life, health and wellbeing [5-7]. Accordingly,
scales to measure chronic disease self-management cannot be
unified. Besides, scales appear to vary with different kinds of
chronic diseases. In mainland China, self-management
assessment scales are mainly disease-specific, such as scales to
measure haemodialysis, liver transplant, hypertension, and
diabetes mellitus [8]. The content of the scales is highly
relevant to the disease which means the scale is only used in
the disease-specific population. However, most patients with
chronic disease, especially community-dwelling elders, have
more than two types of chronic diseases, so a valid and reliable
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generic self-management assessment scale is needed in order to
help professionals to determine individuals’ self-management
abilities in a more holistic way, to provide targeted self-
management interventions and to monitor patient’s behaviour
changes over time [9].
The Partner in Health (PIH) scale is a generic tool, developed
by chronic disease management experts in Australia that has
been psychometrically validated and used with several
population groups and within various contexts to assess
objectively a patient’s self-management knowledge and
behaviours [10]. The development of the scale is based on the
seven Australian nationally agreed principles of self-
management [11]:
1. Knowing about the condition and/or its management.
2. Adopting an agreed self-management care plan negotiated
in partnership with health professionals, significant others
and/or carers and other supporters.
3. Actively sharing in decision-making with health
professionals, significant others and/or carers and other
supporters.
4. Monitoring and managing signs and symptoms of the
condition.
5. Managing the impact of the conditions on the physical,
emotional, occupational and social functioning.
6. Adopting lifestyles that address risk factors and promote
health by focusing on prevention and early intervention.
7. Having access to, and confidence in the ability to use
support services.
The PIH scale has been tested and refined in clinical practice
and research pilots and trials in many countries, such as
Australia, Canada, New Zealand, USA, UK and the
Netherlands [12-21]. It has been translated into Spanish,
Dutch, German, Finnish, Swedish, Malaysian and Korea
[22,23]. These studies have supported it to be an appropriate
outcome measurement tool to evaluate chronic disease self-
management interventions. The updated scale has 12 items
with good internal consistency and validity [24].
The aim of the study was to translate the PIH scale into
Chinese, and test its reliability and structural validity.
Methods
Design
A cross-sectional survey of Chinese community dwelling
patients with chronic diseases was conducted to evaluate the
psychometric properties of the Chinese version of the PIH
Scale. Subjects were recruited in the community health centers
in Changsha, China during November and December 2015.
There were five districts in Changsha city from which we
randomly selected one community health center from each
district, and then 60 patients with chronic diseases were
randomly chosen from each health center.
Ethical considerations
Permissions were obtained from the authors and copyright
owners of the original scale. The study was approved by the
Ethics Committee of Xiangya School of Nursing, Central
South University in China. All patients involved in the study
provided informed, signed consent prior to their participation.
Translation procedures
The translation and validation of the scale strictly followed the
Sousa guideline [25].
Step 1: Forward translation: Two bilingual translators (mother
tongue for both was Chinese: one was a nursing doctoral
student, the other was a non-medical master’s student)
translated the PIH scale and compared the two versions,
respectively. Then the two Chinese versions were sent to the
translation panel (including two bilingual experts, two Chinese
experts, two experts in chronic diseases). They compared the
Chinese version with the English version until all (including
two bilingual translators) reached agreement.
Step 2: Backward translation: Two different bilingual
translators who had not seen the PIH scale (both were studying
abroad and fluent in English: one was a master nursing student,
the other was a non-medical student) translated the Chinese
version back into English. Then they compared the translated
English version with the original English version. Step 1 and
step 2 were repeated until the translated English version
accorded with the original English version.
Step 3: Cultural adaption: The pre-final Chinese version was
sent to the expert panel (five chronic disease experts, two
chronic disease educational experts) to evaluate the item’s
relevance and clarity and scoring criteria. The score for each
item was from 1 (not at all related) to 4 (totally related). At the
same time, we chose 10 patients with chronic diseases to check
the scale’s readability, simplicity and acceptability. Finally, we
got the final Chinese version and sent the final translated
English version to the original scale developers in Australia,
for their final advice, in preparation for the fourth step of pilot
testing.
Study setting and sample selection
Inclusion criteria: Patients with diagnosed diabetes mellitus,
hypertension or both; those who knew the diagnosis; non-
hospitalized patients; those without severe physical or mental
diseases; aged>18 y old; those who could communicate in
Chinese; those signed the informed consents. The reason why
we chose diabetes or hypertension was that these two types of
diseases are routinely managed by Chinese community health
centers.
Patients visiting the health centers during the research period
were identified by the health providers at the health centers on
the basis of the inclusion criteria. Then the researchers selected
target subjects according to the last number of their patient ID,
and provided them with information about the study and
invited their participation.
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Instruments
Chinese partners in health scale (PIH): There are several
PIH editions available, such as a 11-item version a 12-item
2010 version, and a 12-item 2015 version which we chose to
adapt [10,24,26]. The 12-item 2015 version has been validated
in a representative Australian community survey, and the
response categories for items 1-4, 6, 8, 10, 11 and 12 ranged
from 0 (very good) to 8 (very poor); and for items 5, 7, and 9
from 0 (always) to 8 (never). Factor analyses revealed four
related constructs of chronic disease self-management that
were in line with previous PIH research. The four factors were
knowledge (items 1 and 2), partnership (items 3, 4, 5 and 6),
management (items 7 and 8) and coping (items 9, 10, 11 and
12). We chose this most recent version because of the rigor of
its psychometric validation process. The Chinese PIH scale is a
12-item, self-report scale developed to measure chronic disease
patient’s self-management knowledge and behaviours, with
responses scored on a 9-point Likert scale ranging from 0 to 8
where 0 represents low self-management and 8 represents high
self-management. The possible total score was between 0 and
96 across all 12 questions, or between 0 and 8 for each
question (average of the total score). A higher total score
indicates patients with better self-management knowledge and
behaviours.
The Chinese patient activation measure (Chinese PAM):
The PAM scale was originally developed by Hibbard with 22
items and a shortened version with 13-items was widely used
[27,28]. The PAM scale assesses patient self-reported
knowledge, skills and confidence for self-management of one’s
health or chronic condition. It has a conceptual purpose to the
PIH scale and researches have repeatedly shown that a higher
score on the PAM is positively associated with specific self-
care and various health related behaviours. So we choose PAM
as the scale to test the criterion validity of PIH scale. The
Chinese PAM scale is a 13-item self-report scale, with four-
Likert scoring from 1 (strongly disagree) to 4 (strongly agree),
0 (not applicable), the total raw score is between 0 and 52. The
Chinese PAM has good reliability and validity, with
Cronbach’s alpha of 0.81 [29].
Statistical analysis
SPSS software 19.0 was used for statistical analysis. Content
validity for the Chinese PIH scale was assessed using an expert
panel. Test-retest reliability was evaluated by calculating the
intra-class correlation coefficient between pre-test and post-
test, with a 10 d interval in a sample of 21 health professionals.
To assess internal consistency, Cronbach’s alpha coefficients
were calculated for PIH total items. Due to a clear hypothesis
regarding PIH factor structure from a statistical and theoretical
perspective, structural validity was evaluated by confirmatory
factor analysis using Mplus software (version 7.4). Due to
skewed item distributions and the Maximum Likelihood (ML)
assumption of joint normality of all observed and latent
variables, robust standard errors were used for estimation
(MPlus estimator=MLR). Post-estimation modification indices
were calculated to identify any omitted covariance paths that
would otherwise improve model fit. To evaluate how well a 4-
factor measurement model fitted the data, a range of post-
estimation tests were conducted. Likelihood Ratio (LR) test
was used to compare each fitted model with degree of freedom
versus a saturated model with no degree of freedom. At a
practical level, goodness-of-fit indices were calculated to
assess for any discrepancies between models implied data and
observed data based on recommended criteria. These model fit
indices were χ2/df ≤ 2, root mean square error of
approximation (RMSEA<0.06), confirmatory fit index (CFI ≥
0.95), Tucker-Lewis index (TLI ≥ 0.95), and standardized root
mean squared residual (SRMR ≤ 0.08) [30]. In addition,
criterion-related validity was tested using the correlation
between the Chinese PAM and the PIH scale. A P value of less
than 0.05 was considered as statistical significance.
Results
Translation and cultural adaptation
The original item scoring used a 0-8 Likert (nine-point) scale,
with 0 indicating low self-management and 8 indicating high
self-management. However, Chinese patients, especially
elders, are not accustomed to the string scoring without enough
annotation. In another words, only using descriptors of the
anchor points (0 and 8) are inadequate for Chinese patients.
Therefore, we added some annotation by dividing the nine
scores into five grades (for example: “not very well, not well,
not sure, well, very well”) to the original item scoring (Figure
1). A further concern was that the Chinese patients did not
understand the meaning of original item 4 and item 5, so we
adapted the two items greatly through subjects ‘feedback and
experts’ recommendation then reached an agreement with the
original developing group, and the two final items were “I
discuss and determine the treatment methods with health
workers” and “I can communicate with health workers
effectively to get the health services I need which are more
suitable for me” (Figure 1).
Baseline data
Among 300 subjects, a total of 281 subjects completed the
survey with a response rate of 93.7%. All 281 patients were
aged 61.4 ± 11.9 y, ranging from 22-85 y including 145 male
and 136 female. Their baseline data are summarized in Table 1.
As illustrated in Table 2, the mean score of the total PIH scale
was 4.62 (SD=1.005), and there were no floor and ceiling
effects in the 12 items <20% of the respondents achieved the
lowest or highest possible scores.
Reliability
Test-retest reliability: Test-retest reliability was evaluated
using the correlation coefficient. For the Chinese PIH scale, the
correlation coefficient over a 10 d interval in a sample of 21
subjects was 0.832. For this test, a value of >0.61 indicates
substantive test-retest reliability [31].
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Internal consistency reliability: The inter-item correlations
were all positive and between 0.179 and 0.789 (Table 3). The
Cronbach’s alpha coefficient for the total PIH scale was 0.865.
The Cronbach’s alpha if any item deleted was between 0.847
and 0.861. However, all were below the 0.865, so we retained
all 12 items. A Cronbach’s alpha between 0.70 and 0.95 is
regarded as a positive rating for instruments used in research
which suggested the internal consistency and reliability of the
Chinese PIH scale [32].
Figure 1. Difference between original PIH scale and Chinese PIH
scale.
Table 1. Subject’s socio-demographic characteristics (n=281).
Characteristics Mean or N SD or %
Age (Mean and SD) 61.4 11.9










Primary school or below 84 29.9
Junior high school 91 32.4
Senior high school or equivalent 55 19.6
College or above 51 18.2
Disease duration in years (Mean and SD) 8.86 7.17
Table 2. Chinese version of the partners in health scale: means,
standard deviations, and floor and ceiling effects.
 n M SD Floor (%) Ceiling (%)
Item 1 281 4.73 1.48 0.4 4.6
Item 2 281 4.49 1.536 0.7 3.6
Item 3 281 5.56 1.532 0.7 16.4
Item 4 281 3.59 1.836 6.8 2.1
Item 5 281 3.78 1.848 5 2.5
Item 6 281 4.74 1.68 1.8 7.5
Item 7 281 4.4 1.696 2.1 3.6
Item 8 281 4.85 1.644 1.8 7.5
Item 9 281 4.85 1.631 0.4 5.7
Item 10 281 4.74 1.386 0.7 5
Item 11 281 4.88 1.28 0.7 4.6
Item 12 281 4.81 1.637 1.1 6.8
Total score 281 4.62 1.005 0 0.4
Table 3. Sample correlations for the 12-item partners in health scale (n=281).
 PIH8 PIH7 PIH2 PIH1 PIH6 PIH5 PIH4 PIH3 PIH12 PIH11 PIH10 PIH9
PIH8 1            
PIH7 0.45 1
PIH2 0.179 0.331 1
PIH1 0.199 0.288 0.765 1
PIH6 0.404 0.382 0.236 0.216 1
PIH5 0.31 0.446 0.474 0.4 0.406 1
PIH4 0.295 0.451 0.427 0.349 0.327 0.74 1
PIH3 0.265 0.343 0.379 0.344 0.471 0.287 0.241 1
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PIH12 0.266 0.36 0.315 0.337 0.303 0.316 0.21 0.228 1
PIH11 0.2 0.265 0.355 0.369 0.242 0.321 0.223 0.187 0.475 1
PIH10 0.217 0.289 0.346 0.371 0.184 0.336 0.254 0.214 0.382 0.789 1
PIH9 0.298 0.403 0.428 0.401 0.217 0.393 0.259 0.27 0.51 0.719 0.689 1
Figure 2. Structural equation model of partners in health scale
(standardized) (n=281).
Validity
Content validity: The Content Validity Index (CVI) was used
to test the content validity of the Chinese PIH scale. A panel of
experts including five clinical experts from university teaching
hospitals and two faculty members from university were asked
to rate each item of the Chinese PIH scale. They evaluated the
item’s relevance to the scale and scored (from 1=not at all
relevant to 4=totally relevant). The content validity index for
items (I-CVI) was between 0.86 and 1, and the average of the
I-CVIs for all items on the scale (S-CVI/Ave) was 0.965
[33,34]. An I-CVI>0.78 and S-CVI/Ave>0.90 are generally
considered to have good content validity [35].
Correlation coefficient between the PAM and PIH: The
correlation coefficient between the PAM and PIH was 0.505
(p<0.001), which meant they had moderate positive
correlations (Rho between 0.3 and 0.6) [36].
Factor analysis of the Chinese PIH scale: Based on the most
recent PIH validation study we tested a 4-factor model for the
Chinese PIH, i.e. items 1 and 2-knowledge; items 3, 4, 5 and 6-
partnership; items 7 and 8-management; items 9, 10, 11 and
12-coping [24]. The best fitting 4-factor model was a model
with error covariance for items 4 and 5 and items 10 and 11.
All hypothesized factor loadings were positive and significant
when p<0.001 and factor correlation estimates were in the
moderate to large range (0.437-0.877) based on conventional
standards. Results for this model are presented in Figure 2. The
chi-squared results indicated that the model was not a perfect
fit (χ2=84.09, df=46, p=0.001) but it failed to provide a good fit
of the data based on χ2/df=1.83<2, RMSEA=0.054 (90% CI:
0.035-0.072), CFI=0.965, TLI=0.950 and SRMR=0.046.
Discussion
The Chinese PIH scale has acceptable reliability through
testing the internal consistency and test-retest reliability, and
satisfactory validity by evaluating content validity and
construct validity. The four factors of knowledge, partnership,
management and coping reflected the self-management
principles.
Internal consistency is a measure of the extent to which items
in a questionnaire (sub) scale are correlated (homogeneous).
Good internal consistency of items shows that they measure
the same concept and have a good construct. The Cronbach’s
alpha coefficient of the Chinese PIH scale was similar to the
original Australian PIH validation study with 0.82, and the
Spanish PIH validation study with 0.80 [22,26].
Confirmatory factor analysis (CFA) is one method to test the
theoretical constructs or factors represented by a set of items.
The approximate fit indexes were all acceptable except chi-
square value with p<0.05 which proved the model here was
reasonable. Some experts said that the chi-square value was not
a sole index of model fit which was easily affected. There are
conditions that although differences between the sample and
model implied matrices are negligible, the chi-square value is
rejected [37]. Similarities in the wording and context of PIH
questions may also have led to residual covariance between
items 4 and 5, and items 10 and 11. For example, correlating
residual terms for item 10 (I manage the effect of my health
condition (s) on how I feel) and item 11 (I manage the effect of
my health condition (s) on my social life) was credible due to
similar word phrasing as well as tapping into a further minor
factor e.g., feeling isolated.
The validity of the Chinese mandarin PIH scale structure was
commensurate with the previously reported Australian version
but different from the Spanish version and Chinese Hong Kong
version [22,24,38]. The reason why we chose to compare these
versions was that they assessed the same updated 12 items. The
Chinese mandarin version and the updated version have four
factors: knowledge (items 1 and 2), partnership (items 3, 4, 5
and 6), management (items 7 and 8) and coping (items 9, 10,
11 and 12). The initial evaluation of the Spanish PIH scale
used exploratory factor analysis with three dimensions:
knowledge (items 1 and 2), adherence (items 3, 4, 5, 6, 7 and
8), and dealing with or managing side effects (items 9, 10, 11
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and 12). The Spanish result was similar to our result. The main
difference was that our factor divided symptom management
into partnership and management, and maybe a further factor
analysis can get a more detailed and enriched result. The
Chinese Hong Kong version got three factors after removing
item 5 (removed because of less relevance with the whole
scale): knowledge (items 1 and 2), symptom management and
adherence (items 3, 4, 6, 7 and 8), coping (items 9, 10, 11 and
12). After comparing the four versions of PIH scale, we found
that the main difference was with the symptom management
and adherence factor. The Spanish and Hong Kong version did
not separate them further. The reason for this may be that they
tried to accord with the structure of original PIH while the
concept of 12 items of the 2010 version was different from that
of the updated version [26]. And the other two factors of
knowledge and coping were unified, which indicated that the
two concepts were the same in different countries and cultures.
This suggests that analysis with the updated concept was a
better choice.
The study has some limitations. The subjects in the study were
mainly patients with diabetes mellitus and/or hypertension in
community health centers. This may limit, to some extent, the
testing of the Chinese PIH scale’s appropriateness with patients
with other chronic conditions. However, in fact, subjects in the
study were mainly senior age (mean age 61.43) and we did not
exclude subjects with co-morbidities. We plan to test the
Chinese PIH scale with patients suffering from chronic
diseases within the hospital setting and those with complex
chronic diseases, which will modify the Chinese PIH scale
because of the imperfections in the CFA.
Conclusion
In conclusion, the Chinese PIH scale has been proved to be a
valid and reliable instrument for measuring self-management
in Chinese patients with chronic diseases and assessing the
knowledge and behaviours of chronic diseases patients within
community center settings in China. Healthcare providers in
community centers can use the Chinese PIH scale to assess
self-management knowledge, behaviours, strengths and
barriers of patients with chronic diseases, then provide more
effective targeted interventions based on those identified self-
management capabilities, and review their patient’s progress
with self-management over time. Having a reliable tool to
assess self-management in patients with different and various
diseases may benefit health services in China by increasing the
efficiency of assessment of patient’s needs and reduce
healthcare costs as China attempts to cope with the increasing
burden of chronic diseases.
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